Ian Glenn

87 statements · 5 topics · summaries given as host listed separately

Abdominal Wall Defects · episode host Colorectal / ARM & Hirschsprung · episode host Congenital Lung Lesions (CPAM) · episode host Etiologies (Gastroschisis/NEC/Atresia/Volvulus) · episode host Fetal Surgery · episode host Intestinal Failure · episode host Intestinal Rehab · episode host Intestinal Transplant · episode host Motility / Pseudo-obstruction · episode host Short Bowel Syndrome · episode host Single Ventricle / HLHS · guest expert

Featured statements

▶ Ep 1 · 1:12
the risk factors for catheter retention seem to be patients who have chemotherapy infused through their lines, patients who have catheters that are indwelling for longer than about a year and a half. And then there seems to be an association with polyurethane catheter material when compared with silicone catheters.
quote · Catheter Fracture
▶ Ep 3 · 2:31
whenever multiple studies which have looked at patients who actually had retained catheter fragments in follow-up periods from months to the order of 5 years, there weren't any complications. So, no thrombosis associated with the line. Fragments and no infections.
quote · Catheter Fracture
▶ Ep 3 · 0:32
in a couple case series looking retrospectively uh at patients who had catheters removed, anywhere from 5 to 15% of patients are going to require some sort of. Additional intervention to remove the catheter.
quote · Catheter Retention
▶ Ep 1 · 2:04
If you surgically, if you're gonna go in for an immunotomy, tug at the catheter, you run into a risk of bleeding.
quote · Catheter Retention
▶ Ep 1 · 1:35
I think the important thing this paper showed us was that tracheomalacia isn't just one homogeneous disease.
quote · Tracheomalacia
▶ Ep 6 · 2:24
Esophagogastric dissociation is a much bigger surgery than Nissen fundoplication.
clinical · Gastroesophageal Reflux Disease

Nothing matches these filters — clear the search or widen the filters.

Ian's statements about Catheter Fracture 40 statements

Open the Catheter Fracture collection →

Retained Central Venous Catheters

▶ Ep 1 · 0:32
quote in a couple case the looking retrospectively at patients who had catheters removed, anywhere from 5 to 15% of patients are going to require some sort of. Additional intervention to remove the catheter. ↗
▶ Ep 1 · 0:32
quote The actual number of catheters or catheter fragments that get left behind is gonna be from 0.2 to 2%. ↗
▶ Ep 1 · 0:32
epidemiological 5–15% of patients who have catheters removed require some additional intervention (enlarging incision, venotomy, or interventional radiology). ↗
▶ Ep 1 · 0:32
epidemiological 0.2–2% of catheter removals result in at least part of the catheter being left behind. ↗
▶ Ep 1 · 1:12
clinical Risk factors for catheter retention include chemotherapy infusion through the line, indwelling duration longer than about 1.5 years, and polyurethane catheter material compared with silicone. ↗
▶ Ep 1 · 1:12
quote the risk factors for catheter retention seem to be patients who have chemotherapy infused through their lines, patients who have catheters that are indwelling for longer than about a year and a half. And then there seems to be an association with polyurethane catheter material when compared with silicone catheters. ↗
▶ Ep 1 · 1:31
opinion For long-term chemotherapy access, a silastic line should be considered instead of a polyurethane line. ↗
▶ Ep 1 · 2:04
quote If you surgically, if you're gonna go in for an immunotomy, tug at the catheter, you run into a risk of bleeding. ↗
▶ Ep 1 · 2:04
quote in an interventional radiology case series, when they tried to go and endovascularly remove the catheters, there was a risk of the line completely breaking and embolizing distally or of thrombosis occurring during the procedure. ↗
▶ Ep 1 · 2:04
clinical Endovascular retrieval by interventional radiology carries risks of the line completely breaking and embolizing distally or of thrombosis occurring during the procedure. ↗
▶ Ep 1 · 2:04
clinical Surgical venotomy to retrieve a retained catheter carries a risk of bleeding. ↗

Retained Central Venous Catheters

▶ Ep 2 · 0:32
quote in a couple case the looking retrospectively at patients who had catheters removed, anywhere from 5 to 15% of patients are going to require some sort of. Additional intervention to remove the catheter. ↗
▶ Ep 2 · 0:32
epidemiological 5 to 15% of patients who have catheters removed require some sort of additional intervention to remove the catheter. ↗
▶ Ep 2 · 0:32
quote The actual number of catheters or catheter fragments that get left behind is gonna be from 0.2 to 2%. ↗
▶ Ep 2 · 0:32
epidemiological The actual number of catheters or catheter fragments that get left behind is 0.2 to 2%. ↗
▶ Ep 2 · 1:12
clinical There is an association between polyurethane catheter material and catheter retention when compared with silicone catheters. ↗
▶ Ep 2 · 1:12
quote the risk factors for catheter retention seem to be patients who have chemotherapy infused through their lines, patients who have catheters that are indwelling for longer than about a year and a half. And then there seems to be an association with polyurethane catheter material when compared with silicone catheters. ↗
▶ Ep 2 · 1:12
clinical Risk factors for catheter retention include chemotherapy infused through the lines. ↗
▶ Ep 2 · 1:12
clinical Risk factors for catheter retention include catheters that are indwelling for longer than about a year and a half. ↗
▶ Ep 2 · 1:31
opinion For long-term chemotherapy, a silastic line should be considered instead of a polyurethane line. ↗
▶ Ep 2 · 1:42
quote We should be considering maybe a silastic line instead of a polyurethane line. ↗
▶ Ep 2 · 2:04
clinical If you surgically go in for a venotomy and tug at the catheter, you run a risk of bleeding. ↗
▶ Ep 2 · 2:04
clinical In interventional radiology retrieval, there is a risk of the line completely breaking and embolizing distally or of thrombosis occurring during the procedure. ↗
▶ Ep 2 · 2:04
quote If you surgically, if you're gonna go in for an immunotomy, tug at the catheter, you run into a risk of bleeding. ↗

Management of Retained Central Venous Catheters

▶ Ep 3 · 0:32
quote in a couple case series looking retrospectively uh at patients who had catheters removed, anywhere from 5 to 15% of patients are going to require some sort of. Additional intervention to remove the catheter. ↗
▶ Ep 3 · 0:32
epidemiological 5 to 15% of patients who have catheters removed require some sort of additional intervention to remove the catheter. ↗
▶ Ep 3 · 0:57
epidemiological The actual number of catheters or catheter fragments that get left behind is 0.2 to 2%. ↗
▶ Ep 3 · 0:57
quote The actual number of catheters or catheter fragments that get left behind is gonna be from 0.2 to 2%. ↗
▶ Ep 3 · 1:12
clinical Risk factors for catheter retention include catheters that are indwelling for longer than about a year and a half. ↗
▶ Ep 3 · 1:12
clinical Risk factors for catheter retention include chemotherapy infusion through the line. ↗
▶ Ep 3 · 1:12
quote the risk factors for catheter retention seem to be patients who have chemotherapy infused through their lines, patients who have catheters that are indwelling for longer than about a year and a half. And then there seems to be an association with polyurethane catheter material when compared with silicone catheters. ↗
▶ Ep 3 · 1:25
clinical There is an association between polyurethane catheter material and catheter retention when compared with silicone catheters. ↗
▶ Ep 3 · 1:46
guideline The recommendation would be to go with silastic catheters for long-term chemotherapy cases. ↗
▶ Ep 3 · 2:10
clinical Surgical venotomy to retrieve a retained catheter carries a risk of bleeding. ↗
▶ Ep 3 · 2:16
clinical In interventional radiology case series attempting endovascular catheter removal, there was a risk of thrombosis occurring during the procedure. ↗
▶ Ep 3 · 2:16
clinical In interventional radiology case series attempting endovascular catheter removal, there was a risk of the line completely breaking and embolizing distally. ↗
▶ Ep 3 · 2:31
quote whenever multiple studies which have looked at patients who actually had retained catheter fragments in follow-up periods from months to the order of 5 years, there weren't any complications. So, no thrombosis associated with the line. Fragments and no infections. ↗
▶ Ep 3 · 2:31
epidemiological Multiple studies of patients with retained catheter fragments, with follow-up periods from months to the order of 5 years, found no complications. ↗
▶ Ep 3 · 2:42
epidemiological No thrombosis was associated with retained catheter fragments in studies with follow-up from months to 5 years. ↗
▶ Ep 3 · 2:42
epidemiological No infections were associated with retained catheter fragments in studies with follow-up from months to 5 years. ↗
Ian's statements about Catheter Retention 40 statements

Open the Catheter Retention collection →

Retained Central Venous Catheters

▶ Ep 1 · 0:32
epidemiological 5–15% of patients who have catheters removed require some additional intervention (enlarging incision, venotomy, or interventional radiology). ↗
▶ Ep 1 · 0:32
quote in a couple case the looking retrospectively at patients who had catheters removed, anywhere from 5 to 15% of patients are going to require some sort of. Additional intervention to remove the catheter. ↗
▶ Ep 1 · 0:32
quote The actual number of catheters or catheter fragments that get left behind is gonna be from 0.2 to 2%. ↗
▶ Ep 1 · 0:32
epidemiological 0.2–2% of catheter removals result in at least part of the catheter being left behind. ↗
▶ Ep 1 · 1:12
clinical Risk factors for catheter retention include chemotherapy infusion through the line, indwelling duration longer than about 1.5 years, and polyurethane catheter material compared with silicone. ↗
▶ Ep 1 · 1:12
quote the risk factors for catheter retention seem to be patients who have chemotherapy infused through their lines, patients who have catheters that are indwelling for longer than about a year and a half. And then there seems to be an association with polyurethane catheter material when compared with silicone catheters. ↗
▶ Ep 1 · 1:31
opinion For long-term chemotherapy access, a silastic line should be considered instead of a polyurethane line. ↗
▶ Ep 1 · 2:04
quote in an interventional radiology case series, when they tried to go and endovascularly remove the catheters, there was a risk of the line completely breaking and embolizing distally or of thrombosis occurring during the procedure. ↗
▶ Ep 1 · 2:04
clinical Surgical venotomy to retrieve a retained catheter carries a risk of bleeding. ↗
▶ Ep 1 · 2:04
quote If you surgically, if you're gonna go in for an immunotomy, tug at the catheter, you run into a risk of bleeding. ↗
▶ Ep 1 · 2:04
clinical Endovascular retrieval by interventional radiology carries risks of the line completely breaking and embolizing distally or of thrombosis occurring during the procedure. ↗

Retained Central Venous Catheters

▶ Ep 2 · 0:32
epidemiological 5 to 15% of patients who have catheters removed require some sort of additional intervention to remove the catheter. ↗
▶ Ep 2 · 0:32
epidemiological The actual number of catheters or catheter fragments that get left behind is 0.2 to 2%. ↗
▶ Ep 2 · 0:32
quote The actual number of catheters or catheter fragments that get left behind is gonna be from 0.2 to 2%. ↗
▶ Ep 2 · 0:32
quote in a couple case the looking retrospectively at patients who had catheters removed, anywhere from 5 to 15% of patients are going to require some sort of. Additional intervention to remove the catheter. ↗
▶ Ep 2 · 1:12
quote the risk factors for catheter retention seem to be patients who have chemotherapy infused through their lines, patients who have catheters that are indwelling for longer than about a year and a half. And then there seems to be an association with polyurethane catheter material when compared with silicone catheters. ↗
▶ Ep 2 · 1:12
clinical There is an association between polyurethane catheter material and catheter retention when compared with silicone catheters. ↗
▶ Ep 2 · 1:12
clinical Risk factors for catheter retention include catheters that are indwelling for longer than about a year and a half. ↗
▶ Ep 2 · 1:12
clinical Risk factors for catheter retention include chemotherapy infused through the lines. ↗
▶ Ep 2 · 1:31
opinion For long-term chemotherapy, a silastic line should be considered instead of a polyurethane line. ↗
▶ Ep 2 · 1:42
quote We should be considering maybe a silastic line instead of a polyurethane line. ↗
▶ Ep 2 · 2:04
quote If you surgically, if you're gonna go in for an immunotomy, tug at the catheter, you run into a risk of bleeding. ↗
▶ Ep 2 · 2:04
clinical In interventional radiology retrieval, there is a risk of the line completely breaking and embolizing distally or of thrombosis occurring during the procedure. ↗
▶ Ep 2 · 2:04
clinical If you surgically go in for a venotomy and tug at the catheter, you run a risk of bleeding. ↗

Management of Retained Central Venous Catheters

▶ Ep 3 · 0:32
epidemiological 5 to 15% of patients who have catheters removed require some sort of additional intervention to remove the catheter. ↗
▶ Ep 3 · 0:32
quote in a couple case series looking retrospectively uh at patients who had catheters removed, anywhere from 5 to 15% of patients are going to require some sort of. Additional intervention to remove the catheter. ↗
▶ Ep 3 · 0:57
epidemiological The actual number of catheters or catheter fragments that get left behind is 0.2 to 2%. ↗
▶ Ep 3 · 0:57
quote The actual number of catheters or catheter fragments that get left behind is gonna be from 0.2 to 2%. ↗
▶ Ep 3 · 1:12
clinical Risk factors for catheter retention include catheters that are indwelling for longer than about a year and a half. ↗
▶ Ep 3 · 1:12
clinical Risk factors for catheter retention include chemotherapy infusion through the line. ↗
▶ Ep 3 · 1:12
quote the risk factors for catheter retention seem to be patients who have chemotherapy infused through their lines, patients who have catheters that are indwelling for longer than about a year and a half. And then there seems to be an association with polyurethane catheter material when compared with silicone catheters. ↗
▶ Ep 3 · 1:25
clinical There is an association between polyurethane catheter material and catheter retention when compared with silicone catheters. ↗
▶ Ep 3 · 1:46
guideline The recommendation would be to go with silastic catheters for long-term chemotherapy cases. ↗
▶ Ep 3 · 2:10
clinical Surgical venotomy to retrieve a retained catheter carries a risk of bleeding. ↗
▶ Ep 3 · 2:16
clinical In interventional radiology case series attempting endovascular catheter removal, there was a risk of the line completely breaking and embolizing distally. ↗
▶ Ep 3 · 2:16
clinical In interventional radiology case series attempting endovascular catheter removal, there was a risk of thrombosis occurring during the procedure. ↗
▶ Ep 3 · 2:31
epidemiological Multiple studies of patients with retained catheter fragments, with follow-up periods from months to the order of 5 years, found no complications. ↗
▶ Ep 3 · 2:31
quote whenever multiple studies which have looked at patients who actually had retained catheter fragments in follow-up periods from months to the order of 5 years, there weren't any complications. So, no thrombosis associated with the line. Fragments and no infections. ↗
▶ Ep 3 · 2:42
epidemiological No thrombosis was associated with retained catheter fragments in studies with follow-up from months to 5 years. ↗
▶ Ep 3 · 2:42
epidemiological No infections were associated with retained catheter fragments in studies with follow-up from months to 5 years. ↗
Ian's statements about Gastroesophageal Reflux Disease 2 statements

Open the Gastroesophageal Reflux Disease collection →

Esophagogastric Dissociation for GERD in Severe Neurodisability

▶ Ep 6 · 2:24
clinical Esophagogastric dissociation is a much bigger surgery than Nissen fundoplication. ↗
▶ Ep 6 · 2:24
quote Yeah, it's definitely a much bigger surgery. ↗
Ian's statements about Gastroesophageal Reflux Disease 2 statements

Open the Gastroesophageal Reflux Disease collection →

Esophagogastric Dissociation for GERD in Severe Neurodisability

▶ Ep 6 · 2:24
quote Yeah, it's definitely a much bigger surgery. ↗
▶ Ep 6 · 2:24
clinical Esophagogastric dissociation is a much bigger surgery than Nissen fundoplication. ↗
Ian's statements about Tracheomalacia 3 statements

Open the Tracheomalacia collection →

Posterior Tracheopexy For Severe Tracheomalacia

▶ Ep 1 · 1:58
opinion There is a need for standardization in the approach to tracheomalacia. ↗

Posterior Tracheopexy For Severe Tracheomalacia

▶ Ep 1 · 1:35
quote I think the important thing this paper showed us was that tracheomalacia isn't just one homogeneous disease. ↗
▶ Ep 1 · 1:58
opinion There is a need for standardization in the treatment of tracheomalacia. ↗

Summaries Ian gave as host · 98 summaries

Recaps of other experts' statements, not Ian's own clinical position.

Summaries Ian gave as host · Abdominal Wall Defects 1 summary

Open the Abdominal Wall Defects collection →

Intestinal Failure with Dr. Brad Warner

▶ Ep 17 · 0:04
host summary Ian Glenn summarizes what Dr. Brad Warner said: This episode features Doctor Brad Warner from Washington University in Saint Louis and Saint Louis Children's Hospital. ↗
Summaries Ian gave as host · Colorectal / ARM & Hirschsprung 1 summary

Open the Colorectal / ARM & Hirschsprung collection →

Intestinal Failure with Dr. Brad Warner

▶ Ep 73 · 0:04
host summary Ian Glenn summarizes what Dr. Brad Warner said: This episode features Doctor Brad Warner from Washington University in Saint Louis and Saint Louis Children's Hospital. ↗
Summaries Ian gave as host · Etiologies (Gastroschisis/NEC/Atresia/Volvulus) 1 summary

Open the Etiologies (Gastroschisis/NEC/Atresia/Volvulus) collection →

Intestinal Failure with Dr. Brad Warner

▶ Ep 24 · 0:04
host summary Ian Glenn summarizes what Dr. Brad Warner said: This episode features Doctor Brad Warner from Washington University in Saint Louis and Saint Louis Children's Hospital. ↗
Summaries Ian gave as host · Gastroesophageal Reflux Disease 28 summaries

Open the Gastroesophageal Reflux Disease collection →

Esophagogastric Dissociation for GERD in Severe Neurodisability

▶ Ep 4 · 1:01
host summary Ian Glenn summarizing a resource: In the study, operative failure was defined as either recurrence of preoperative reflux symptoms or requirement of additional anti-reflux surgery. ↗
▶ Ep 4 · 1:01
host summary Ian Glenn summarizing a resource: Primary outcome was operative failure, which they defined as either recurrence of their preoperative reflux symptoms or a requirement of an additional uh anti-reflux surgery. ↗
▶ Ep 4 · 1:13
host summary Ian Glenn summarizing a resource: there was a 4% failure rate in the esophagogastric dissociation group, there was a 21% failure rate in the Nissen group. However, that wasn't statistically significant. ↗
▶ Ep 4 · 1:13
host summary Ian Glenn summarizing a resource: The esophagogastric dissociation group had a 4% operative failure rate. ↗
▶ Ep 4 · 1:13
host summary Ian Glenn summarizing a resource: The Nissen fundoplication group had a 21% operative failure rate. ↗
▶ Ep 4 · 1:21
host summary Ian Glenn summarizing a resource: The difference in operative failure rates between esophagogastric dissociation and Nissen fundoplication was not statistically significant. ↗
▶ Ep 4 · 1:23
host summary Ian Glenn summarizing a resource: 54% of patients in the Nissen fundoplication group continued to require anti-reflux medications after surgery. ↗
▶ Ep 4 · 1:23
host summary Ian Glenn summarizing a resource: 17% of patients in the esophagogastric dissociation group continued to require anti-reflux medications after surgery. ↗
▶ Ep 4 · 1:23
host summary Ian Glenn summarizing a resource: The difference in continued requirement for anti-reflux medications between groups was statistically significant. ↗
▶ Ep 4 · 1:29
host summary Ian Glenn summarizing a resource: 17% of the patients in the esophagogastric dissociation group continued to require them, whereas 54% required it in the Nissan group, um, and that was statistically significant. ↗
▶ Ep 4 · 1:39
host summary Ian Glenn summarizing a resource: Caregiver-evaluated quality of life and symptom scores were the same between the esophagogastric dissociation and Nissen groups. ↗
▶ Ep 4 · 2:03
host summary Ian Glenn summarizing a resource: this could potentially be a type 2 error where there was actually a difference between the two groups and the sample size was just a little bit too small to detect that. ↗
▶ Ep 4 · 2:03
host summary Ian Glenn summarizing a resource: The lack of statistical significance in operative failure rates could represent a type 2 error where the sample size was too small to detect an actual difference. ↗
▶ Ep 4 · 2:26
host summary Ian Glenn summarizing a resource: The study examined perioperative factors including OR time, length of hospital stay, need for ICU stay, and time to full feeds, finding statistically significant differences following expected trends. ↗
▶ Ep 4 · 2:39
host summary Ian Glenn summarizing a resource: The study did not report on leaks, strictures, or long-term requirement for additional surgeries other than anti-reflux operations. ↗

Esophagogastric Dissociation for GERD in Severe Neurodisability

▶ Ep 6 · 0:48
host summary Ian Glenn summarizing a resource: The study compared patients with severe GERD and neurologic disability, half undergoing esophagogastric dissociation and half undergoing laparoscopic Nissen. ↗
▶ Ep 6 · 1:01
host summary Ian Glenn summarizing a resource: Primary outcome was operative failure, which they defined as either recurrence of their preoperative reflux symptoms or a requirement of an additional uh anti-reflux surgery. ↗
▶ Ep 6 · 1:01
host summary Ian Glenn summarizing a resource: Primary outcome was operative failure, defined as either recurrence of preoperative reflux symptoms or requirement of additional anti-reflux surgery. ↗
▶ Ep 6 · 1:13
host summary Ian Glenn summarizing a resource: There was a 4% failure rate in the esophagogastric dissociation group and a 21% failure rate in the Nissen group. ↗
▶ Ep 6 · 1:21
host summary Ian Glenn summarizing a resource: The difference in failure rates between esophagogastric dissociation (4%) and Nissen (21%) was not statistically significant. ↗
▶ Ep 6 · 1:23
host summary Ian Glenn summarizing a resource: 17% of patients in the esophagogastric dissociation group continued to require anti-reflux medications after surgery, compared to 54% in the Nissen group. ↗
▶ Ep 6 · 1:29
host summary Ian Glenn summarizing a resource: The difference in continued requirement for anti-reflux medications (17% vs 54%) was statistically significant. ↗
▶ Ep 6 · 1:39
host summary Ian Glenn summarizing a resource: Caregiver-evaluated quality of life and symptom scores were the same between the two groups with no statistically significant difference. ↗
▶ Ep 6 · 1:46
host summary Ian Glenn summarizing a resource: So there's no statistically significant difference there. ↗
▶ Ep 6 · 2:03
host summary Ian Glenn summarizing a resource: The lack of statistical significance in failure rates could potentially be a type 2 error where there was actually a difference but the sample size was too small to detect it. ↗
▶ Ep 6 · 2:03
host summary Ian Glenn summarizing a resource: And the authors brought up that this could potentially be a type 2 error where there was actually a difference between the two groups and the sample size was just a little bit too small to detect that. ↗
▶ Ep 6 · 2:26
host summary Ian Glenn summarizing a resource: The study examined perioperative factors including time in the OR, length of hospital stay, need for ICU stay, and time to full feeds, with statistically significant differences following expected trends. ↗
▶ Ep 6 · 2:39
host summary Ian Glenn summarizing a resource: The study did not report on leaks, strictures, or long-term requirement for additional surgeries other than anti-reflux operations. ↗
Summaries Ian gave as host · Gastroesophageal Reflux Disease 28 summaries

Open the Gastroesophageal Reflux Disease collection →

Esophagogastric Dissociation for GERD in Severe Neurodisability

▶ Ep 4 · 1:01
host summary Ian Glenn summarizing a resource: In the study, operative failure was defined as either recurrence of preoperative reflux symptoms or requirement of additional anti-reflux surgery. ↗
▶ Ep 4 · 1:01
host summary Ian Glenn summarizing a resource: Primary outcome was operative failure, which they defined as either recurrence of their preoperative reflux symptoms or a requirement of an additional uh anti-reflux surgery. ↗
▶ Ep 4 · 1:13
host summary Ian Glenn summarizing a resource: The esophagogastric dissociation group had a 4% operative failure rate. ↗
▶ Ep 4 · 1:13
host summary Ian Glenn summarizing a resource: there was a 4% failure rate in the esophagogastric dissociation group, there was a 21% failure rate in the Nissen group. However, that wasn't statistically significant. ↗
▶ Ep 4 · 1:13
host summary Ian Glenn summarizing a resource: The Nissen fundoplication group had a 21% operative failure rate. ↗
▶ Ep 4 · 1:21
host summary Ian Glenn summarizing a resource: The difference in operative failure rates between esophagogastric dissociation and Nissen fundoplication was not statistically significant. ↗
▶ Ep 4 · 1:23
host summary Ian Glenn summarizing a resource: 17% of patients in the esophagogastric dissociation group continued to require anti-reflux medications after surgery. ↗
▶ Ep 4 · 1:23
host summary Ian Glenn summarizing a resource: 54% of patients in the Nissen fundoplication group continued to require anti-reflux medications after surgery. ↗
▶ Ep 4 · 1:23
host summary Ian Glenn summarizing a resource: The difference in continued requirement for anti-reflux medications between groups was statistically significant. ↗
▶ Ep 4 · 1:29
host summary Ian Glenn summarizing a resource: 17% of the patients in the esophagogastric dissociation group continued to require them, whereas 54% required it in the Nissan group, um, and that was statistically significant. ↗
▶ Ep 4 · 1:39
host summary Ian Glenn summarizing a resource: Caregiver-evaluated quality of life and symptom scores were the same between the esophagogastric dissociation and Nissen groups. ↗
▶ Ep 4 · 2:03
host summary Ian Glenn summarizing a resource: this could potentially be a type 2 error where there was actually a difference between the two groups and the sample size was just a little bit too small to detect that. ↗
▶ Ep 4 · 2:03
host summary Ian Glenn summarizing a resource: The lack of statistical significance in operative failure rates could represent a type 2 error where the sample size was too small to detect an actual difference. ↗
▶ Ep 4 · 2:26
host summary Ian Glenn summarizing a resource: The study examined perioperative factors including OR time, length of hospital stay, need for ICU stay, and time to full feeds, finding statistically significant differences following expected trends. ↗
▶ Ep 4 · 2:39
host summary Ian Glenn summarizing a resource: The study did not report on leaks, strictures, or long-term requirement for additional surgeries other than anti-reflux operations. ↗

Esophagogastric Dissociation for GERD in Severe Neurodisability

▶ Ep 6 · 0:48
host summary Ian Glenn summarizing a resource: The study compared patients with severe GERD and neurologic disability, half undergoing esophagogastric dissociation and half undergoing laparoscopic Nissen. ↗
▶ Ep 6 · 1:01
host summary Ian Glenn summarizing a resource: Primary outcome was operative failure, defined as either recurrence of preoperative reflux symptoms or requirement of additional anti-reflux surgery. ↗
▶ Ep 6 · 1:01
host summary Ian Glenn summarizing a resource: Primary outcome was operative failure, which they defined as either recurrence of their preoperative reflux symptoms or a requirement of an additional uh anti-reflux surgery. ↗
▶ Ep 6 · 1:13
host summary Ian Glenn summarizing a resource: There was a 4% failure rate in the esophagogastric dissociation group and a 21% failure rate in the Nissen group. ↗
▶ Ep 6 · 1:21
host summary Ian Glenn summarizing a resource: The difference in failure rates between esophagogastric dissociation (4%) and Nissen (21%) was not statistically significant. ↗
▶ Ep 6 · 1:23
host summary Ian Glenn summarizing a resource: 17% of patients in the esophagogastric dissociation group continued to require anti-reflux medications after surgery, compared to 54% in the Nissen group. ↗
▶ Ep 6 · 1:29
host summary Ian Glenn summarizing a resource: The difference in continued requirement for anti-reflux medications (17% vs 54%) was statistically significant. ↗
▶ Ep 6 · 1:39
host summary Ian Glenn summarizing a resource: Caregiver-evaluated quality of life and symptom scores were the same between the two groups with no statistically significant difference. ↗
▶ Ep 6 · 1:46
host summary Ian Glenn summarizing a resource: So there's no statistically significant difference there. ↗
▶ Ep 6 · 2:03
host summary Ian Glenn summarizing a resource: The lack of statistical significance in failure rates could potentially be a type 2 error where there was actually a difference but the sample size was too small to detect it. ↗
▶ Ep 6 · 2:03
host summary Ian Glenn summarizing a resource: And the authors brought up that this could potentially be a type 2 error where there was actually a difference between the two groups and the sample size was just a little bit too small to detect that. ↗
▶ Ep 6 · 2:26
host summary Ian Glenn summarizing a resource: The study examined perioperative factors including time in the OR, length of hospital stay, need for ICU stay, and time to full feeds, with statistically significant differences following expected trends. ↗
▶ Ep 6 · 2:39
host summary Ian Glenn summarizing a resource: The study did not report on leaks, strictures, or long-term requirement for additional surgeries other than anti-reflux operations. ↗
Summaries Ian gave as host · Hirschsprung disease 1 summary

Open the Hirschsprung disease collection →

Intestinal Failure with Dr. Brad Warner

▶ Ep 29 · 0:04
host summary Ian Glenn summarizes what Dr. Brad Warner said: This episode features Doctor Brad Warner from Washington University in Saint Louis and Saint Louis Children's Hospital. ↗
Summaries Ian gave as host · Intestinal Failure 1 summary

Open the Intestinal Failure collection →

Intestinal Failure with Dr. Brad Warner

▶ Ep 6 · 0:04
host summary Ian Glenn summarizes what Dr. Brad Warner said: This episode features Doctor Brad Warner from Washington University in Saint Louis and Saint Louis Children's Hospital. ↗
Summaries Ian gave as host · Intestinal Rehab 1 summary

Open the Intestinal Rehab collection →

Intestinal Failure with Dr. Brad Warner

▶ Ep 33 · 0:04
host summary Ian Glenn summarizes what Dr. Brad Warner said: This episode features Doctor Brad Warner from Washington University in Saint Louis and Saint Louis Children's Hospital. ↗
Summaries Ian gave as host · Intestinal Transplant 1 summary

Open the Intestinal Transplant collection →

Intestinal Failure with Dr. Brad Warner

▶ Ep 3 · 0:04
host summary Ian Glenn summarizes what Dr. Brad Warner said: This episode features Doctor Brad Warner from Washington University in Saint Louis and Saint Louis Children's Hospital. ↗
Summaries Ian gave as host · Intussusception 1 summary

Open the Intussusception collection →

Intussusception - Soft Tissue Abscess - Pilonidal Cyst - Bleeding Meckel's...

▶ Ep 2 · 13:04
host summary Ian Glenn summarizing the discussion: The Karydakis flap is superior to excision alone for pilonidal disease and comparable to the modified Limberg flap; the modified elliptical rotation flap has comparable short-term results. ↗
Summaries Ian gave as host · Intussusception 1 summary

Open the Intussusception collection →

Intussusception - Soft Tissue Abscess - Pilonidal Cyst - Bleeding Meckel's...

▶ Ep 1 · 13:04
host summary Ian Glenn summarizing the discussion: The Karydakis flap is superior to excision alone for pilonidal disease and comparable to the modified Limberg flap; the modified elliptical rotation flap has comparable short-term results. ↗
Summaries Ian gave as host · Motility / Pseudo-obstruction 1 summary

Open the Motility / Pseudo-obstruction collection →

Intestinal Failure with Dr. Brad Warner

▶ Ep 1 · 0:04
host summary Ian Glenn summarizes what Dr. Brad Warner said: This episode features Doctor Brad Warner from Washington University in Saint Louis and Saint Louis Children's Hospital. ↗
Summaries Ian gave as host · Short Bowel Syndrome 1 summary

Open the Short Bowel Syndrome collection →

Intestinal Failure with Dr. Brad Warner

▶ Ep 1 · 0:04
host summary Ian Glenn summarizes what Dr. Brad Warner said: This episode features Doctor Brad Warner from Washington University in Saint Louis and Saint Louis Children's Hospital. ↗
Summaries Ian gave as host · Short Gut Syndrome 1 summary

Open the Short Gut Syndrome collection →

Intestinal Failure with Dr. Brad Warner

▶ Ep 2 · 0:04
host summary Ian Glenn summarizes what Dr. Brad Warner said: This episode features Doctor Brad Warner from Washington University in Saint Louis and Saint Louis Children's Hospital. ↗
Summaries Ian gave as host · Tracheomalacia 30 summaries

Open the Tracheomalacia collection →

Posterior Tracheopexy For Severe Tracheomalacia

▶ Ep 1 · 0:16
host summary Ian Glenn summarizing a resource: The paper by first author Hester Sche and last author Russell Jennings examined 98 patients who had severe tracheomalacia with posterior membranous intrusion. ↗
▶ Ep 1 · 0:16
host summary Ian Glenn summarizing a resource: This paper is about patients who have tracheomalacia and specifically it's called Posterior tracheopexy for severe tracheomalacia. ↗
▶ Ep 1 · 0:35
host summary Ian Glenn summarizing a resource: All patients received bronchoscopy showing the trachea tended to collapse inward from the posterior aspect. ↗
▶ Ep 1 · 0:44
host summary Ian Glenn summarizing a resource: The authors distinguished between anterior compression (from the aortic arch) and posterior compression (collapse). ↗
▶ Ep 1 · 0:54
host summary Ian Glenn summarizing a resource: Posterior tracheopexy involves taking pledgeted sutures and sewing the posterior wall of the trachea to the anterior longitudinal ligament of the spine. ↗
▶ Ep 1 · 1:05
host summary Ian Glenn summarizing a resource: 88% of the 98 patients had esophageal atresia with or without TEF. ↗
▶ Ep 1 · 1:05
host summary Ian Glenn summarizing a resource: Patients were followed anywhere from 1 week to 36 months. ↗
▶ Ep 1 · 1:15
host summary Ian Glenn summarizing a resource: Clinical symptoms including cough, barking cough, noisy breathing, and infections improved across the board. ↗
▶ Ep 1 · 1:25
host summary Ian Glenn summarizing a resource: Patients improved on bronchoscopic evaluation. ↗
▶ Ep 1 · 1:30
host summary Ian Glenn summarizing a resource: Exercise tolerance did not improve statistically but showed a trend towards improvement. ↗
▶ Ep 1 · 1:35
host summary Ian Glenn summarizing a resource: I think the important thing this paper showed us was that tracheomalacia isn't just one homogeneous disease. ↗
▶ Ep 1 · 1:35
host summary Ian Glenn summarizing a resource: Tracheomalacia is not a homogeneous disease. ↗
▶ Ep 1 · 1:41
host summary Ian Glenn summarizing a resource: The paper emphasized the importance of systematic bronchoscopic evaluation. ↗
▶ Ep 1 · 1:45
host summary Ian Glenn summarizing a resource: Some patients benefit from posterior tracheopexy, some from aortopexy or anterior approach, and some need both. ↗
▶ Ep 1 · 1:54
host summary Ian Glenn summarizing a resource: Approximately 20% of patients in the study required both posterior tracheopexy and aortopexy. ↗

Posterior Tracheopexy For Severe Tracheomalacia

▶ Ep 1 · 0:16
host summary Ian Glenn summarizing a resource: This paper is about patients who have tracheomalacia and specifically it's called Posterior tracheopexy for severe tracheomalacia. ↗
▶ Ep 1 · 0:24
host summary Ian Glenn summarizing a resource: The first author is Hester She and the last author is Russell Jennings. ↗
▶ Ep 1 · 0:28
host summary Ian Glenn summarizing a resource: The paper examined 98 patients who had severe tracheomalacia with posterior membranous intrusion. ↗
▶ Ep 1 · 0:35
host summary Ian Glenn summarizing a resource: All patients received bronchoscopy showing the trachea tended to collapse inward from the posterior aspect. ↗
▶ Ep 1 · 0:44
host summary Ian Glenn summarizing a resource: The study distinguished between anterior compression (from the aortic arch) and posterior compression (collapse). ↗
▶ Ep 1 · 0:54
host summary Ian Glenn summarizing a resource: Posterior tracheopexy involves taking pledgeted sutures and sewing the posterior wall of the trachea to the anterior longitudinal ligament of the spine. ↗
▶ Ep 1 · 1:05
host summary Ian Glenn summarizing a resource: 88% of the 98 patients had esophageal atresia with or without TEF. ↗
▶ Ep 1 · 1:05
host summary Ian Glenn summarizing a resource: Patients were followed anywhere from 1 week to 36 months. ↗
▶ Ep 1 · 1:15
host summary Ian Glenn summarizing a resource: Clinical symptoms improved pretty much across the board, including cough, barking cough, noisy breathing, and infections. ↗
▶ Ep 1 · 1:25
host summary Ian Glenn summarizing a resource: Patients improved on bronchoscopic evaluation. ↗
▶ Ep 1 · 1:30
host summary Ian Glenn summarizing a resource: Exercise tolerance did not improve statistically but showed a trend towards improvement. ↗
▶ Ep 1 · 1:35
host summary Ian Glenn summarizing a resource: Tracheomalacia is not one homogeneous disease. ↗
▶ Ep 1 · 1:41
host summary Ian Glenn summarizing a resource: The paper emphasized the importance of systematic bronchoscopic evaluation. ↗
▶ Ep 1 · 1:45
host summary Ian Glenn summarizing a resource: Some patients benefit from posterior tracheopexy, some from aortopexy or anterior approach, and some need both. ↗
▶ Ep 1 · 1:54
host summary Ian Glenn summarizing a resource: Almost 20% of patients in the study required both posterior tracheopexy and aortopexy. ↗